Avalo Therapeutics Stock Price History
| AVTX Stock | USD 8.22 0.23 2.88% |
Below is the normalized historical share price chart for Avalo Therapeutics extending back to November 13, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avalo Therapeutics stands at 8.22, as last reported on the 20th of March, with the highest price reaching 8.30 and the lowest price hitting 7.65 during the day.
If you're considering investing in Avalo Stock, it is important to understand the factors that can impact its price. At this stage we consider Avalo Stock to be relatively risky. Avalo Therapeutics secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of standard deviation over the last 3 months. We have found twenty-three technical indicators for Avalo Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Avalo Therapeutics' risk adjusted performance of (0), and Mean Deviation of 4.3 to double-check if the risk estimate we provide is consistent with the expected return of 0.0385%.
At this time, Avalo Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 11.3 M in 2025, whereas Common Stock is likely to drop 9,500 in 2025. . Price To Sales Ratio is likely to drop to 130.10 in 2025. Price Earnings Ratio is likely to drop to -1.81 in 2025. Avalo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of November 2015 | 200 Day MA 9.8553 | 50 Day MA 7.443 | Beta 0.864 |
Avalo |
Sharpe Ratio = 0.0064
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVTX |
Estimated Market Risk
| 6.02 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Avalo Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avalo Therapeutics by adding Avalo Therapeutics to a well-diversified portfolio.
Price Book 3.9806 | Enterprise Value Ebitda (0.19) | Price Sales 102.311 | Shares Float 3.5 M | Wall Street Target Price 33 |
Avalo Therapeutics Stock Price History Chart
There are several ways to analyze Avalo Stock price data. The simplest method is using a basic Avalo candlestick price chart, which shows Avalo Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 23, 2024 | 9.09 |
| Lowest Price | January 15, 2025 | 6.32 |
Avalo Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Avalo Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Avalo Stock. It can be used to describe the percentage change in the price of Avalo Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Avalo Stock.| Avalo Therapeutics Accumulation Distribution | 2,166 | |
| Avalo Therapeutics Price Daily Balance Of Power | 0.35 | |
| Avalo Therapeutics Price Action Indicator | 0.36 | |
| Avalo Therapeutics Price Rate Of Daily Change | 1.03 |
Avalo Therapeutics March 20, 2025 Stock Price Analysis
Avalo Stock Price History Data
The price series of Avalo Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 3.1 with a coefficient of variation of 10.52. The prices are distributed with arithmetic mean of 7.78. The median price for the last 90 days is 7.7. The company had 1:240 stock split on 29th of December 2023.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 7.99 | 8.30 | 7.65 | 8.22 | 27,662 | |
| 03/19/2025 | 7.60 | 8.00 | 7.60 | 7.99 | 8,115 | |
| 03/18/2025 | 7.70 | 7.88 | 7.28 | 7.77 | 25,787 | |
| 03/17/2025 | 7.69 | 7.80 | 7.06 | 7.69 | 34,509 | |
| 03/14/2025 | 7.43 | 7.56 | 7.09 | 7.39 | 36,384 | |
| 03/13/2025 | 7.64 | 7.98 | 7.21 | 7.42 | 33,381 | |
| 03/12/2025 | 8.05 | 8.11 | 7.41 | 7.70 | 27,454 | |
| 03/11/2025 | 7.14 | 8.40 | 7.07 | 7.99 | 1,228,478 | |
| 03/10/2025 | 7.80 | 8.25 | 7.01 | 7.19 | 44,009 | |
| 03/07/2025 | 7.36 | 8.90 | 7.00 | 7.76 | 124,922 | |
| 03/06/2025 | 6.85 | 7.71 | 6.83 | 7.33 | 21,899 | |
| 03/05/2025 | 6.94 | 7.17 | 6.48 | 6.98 | 29,218 | |
| 03/04/2025 | 6.38 | 7.28 | 6.38 | 6.90 | 24,907 | |
| 03/03/2025 | 7.31 | 7.31 | 6.55 | 6.70 | 25,958 | |
| 02/28/2025 | 6.99 | 7.33 | 6.35 | 7.31 | 48,816 | |
| 02/27/2025 | 6.83 | 6.90 | 6.49 | 6.60 | 14,882 | |
| 02/26/2025 | 7.15 | 7.15 | 6.70 | 6.70 | 24,584 | |
| 02/25/2025 | 8.10 | 8.10 | 6.82 | 7.25 | 52,026 | |
| 02/24/2025 | 8.71 | 11.23 | 8.00 | 8.10 | 175,539 | |
| 02/21/2025 | 7.98 | 8.65 | 7.36 | 8.44 | 47,862 | |
| 02/20/2025 | 7.28 | 7.28 | 6.81 | 7.16 | 21,443 | |
| 02/19/2025 | 7.12 | 7.18 | 6.88 | 6.99 | 32,673 | |
| 02/18/2025 | 7.47 | 7.47 | 7.01 | 7.09 | 26,566 | |
| 02/14/2025 | 7.77 | 8.00 | 7.29 | 7.35 | 49,083 | |
| 02/13/2025 | 7.81 | 7.91 | 7.61 | 7.73 | 30,474 | |
| 02/12/2025 | 7.68 | 7.97 | 7.42 | 7.68 | 21,783 | |
| 02/11/2025 | 8.01 | 8.11 | 7.58 | 7.66 | 28,752 | |
| 02/10/2025 | 8.11 | 8.18 | 7.90 | 7.96 | 9,170 | |
| 02/07/2025 | 8.14 | 8.20 | 7.79 | 8.18 | 22,978 | |
| 02/06/2025 | 8.38 | 8.38 | 7.95 | 8.19 | 11,978 | |
| 02/05/2025 | 8.16 | 8.50 | 7.94 | 8.38 | 34,992 | |
| 02/04/2025 | 8.19 | 8.45 | 7.90 | 8.11 | 40,078 | |
| 02/03/2025 | 8.17 | 8.80 | 7.82 | 8.02 | 40,933 | |
| 01/31/2025 | 8.08 | 8.60 | 7.91 | 8.42 | 44,386 | |
| 01/30/2025 | 7.52 | 8.28 | 7.36 | 7.90 | 45,776 | |
| 01/29/2025 | 7.83 | 8.50 | 7.42 | 7.60 | 51,336 | |
| 01/28/2025 | 7.19 | 8.07 | 7.05 | 8.04 | 36,161 | |
| 01/27/2025 | 7.60 | 8.44 | 7.08 | 7.16 | 54,633 | |
| 01/24/2025 | 7.66 | 7.75 | 7.27 | 7.54 | 104,595 | |
| 01/23/2025 | 6.60 | 7.96 | 6.50 | 7.58 | 150,053 | |
| 01/22/2025 | 6.73 | 6.85 | 6.50 | 6.59 | 11,071 | |
| 01/21/2025 | 6.85 | 7.43 | 6.76 | 6.90 | 61,118 | |
| 01/17/2025 | 6.73 | 6.83 | 6.04 | 6.75 | 238,024 | |
| 01/16/2025 | 6.23 | 7.17 | 6.20 | 6.73 | 77,926 | |
| 01/15/2025 | 6.53 | 6.90 | 5.99 | 6.32 | 112,300 | |
| 01/14/2025 | 6.85 | 6.87 | 6.36 | 6.52 | 23,589 | |
| 01/13/2025 | 7.04 | 7.47 | 6.60 | 6.87 | 63,520 | |
| 01/10/2025 | 6.91 | 7.25 | 6.70 | 7.00 | 89,700 | |
| 01/08/2025 | 7.50 | 7.50 | 6.78 | 7.03 | 114,323 | |
| 01/07/2025 | 8.19 | 8.20 | 7.14 | 7.51 | 106,477 | |
| 01/06/2025 | 8.44 | 8.97 | 7.76 | 7.98 | 80,709 | |
| 01/03/2025 | 8.55 | 8.99 | 8.00 | 8.39 | 88,968 | |
| 01/02/2025 | 7.50 | 8.70 | 7.50 | 8.43 | 97,929 | |
| 12/31/2024 | 7.80 | 8.14 | 7.34 | 7.43 | 44,833 | |
| 12/30/2024 | 8.24 | 8.33 | 7.36 | 7.80 | 54,238 | |
| 12/27/2024 | 9.10 | 9.27 | 8.10 | 8.33 | 102,852 | |
| 12/26/2024 | 8.55 | 9.38 | 8.19 | 9.09 | 94,858 | |
| 12/24/2024 | 9.13 | 9.41 | 8.67 | 8.81 | 38,734 | |
| 12/23/2024 | 8.89 | 9.40 | 8.01 | 9.09 | 181,361 | |
| 12/20/2024 | 9.10 | 9.81 | 8.67 | 8.91 | 949,861 | |
| 12/19/2024 | 9.99 | 9.99 | 9.08 | 9.08 | 65,099 |
About Avalo Therapeutics Stock history
Avalo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avalo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avalo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avalo Therapeutics stock prices may prove useful in developing a viable investing in Avalo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.8 M | 11.3 M | |
| Net Loss | -75.9 M | -72.1 M |
Avalo Therapeutics Stock Technical Analysis
Avalo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Avalo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Avalo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Avalo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avalo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | 0.3899 | |||
| Treynor Ratio | (0.26) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Avalo Stock Analysis
When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.